
Here's How Generative AI Factors Into Nvidia's Plan for Growth
A handful of companies seem to be at the center of the artificial intelligence (AI) universe, and Nvidia (NASDAQ: NVDA) is certainly one of them. The company's unique ability to design some of the most advanced processors for AI has vaulted its status, not to mention its share price, over the past several years.
Nvidia's management has talked extensively about generative AI on recent earnings calls, according to research from The Motley Fool. But what, exactly, are Nvidia's long-term prospects from generative AI? Here are three of the biggest opportunities.
1. Data center spending is through the roof
You've probably noticed a lot of technology companies talk about AI spending lately. The figures are often in the billions of dollars, but what is most of that money being spent on? In many cases, data center infrastructure.
The world's largest tech companies are in an AI race and almost all of them have pulled out their checkbooks to try to win it. Nvidia benefits no matter where the money is coming from because it designs processors that work perfectly for training advanced AI models.
To continue developing new AI models and processing all of the requests being made by current ones, companies need to upgrade their data centers to accelerate their computing power. That means, according to Nvidia's earnings calls, that tech giants are transitioning from general-purpose data centers to AI ones.
The opportunity here is massive. Nvidia CEO Jenson Huang thinks AI data center spending will reach $2 trillion in the next five years alone. The spending is already paying off for the company, with Nvidia's data center revenue more than doubling to $30.8 billion in the fiscal third quarter (which ended Oct. 27).
2. AI cloud computing services are on the rise
This opportunity goes hand in hand with data center spending, but I want to break it out into its own category because I think it's important to distinguish between AI data center spending and AI cloud services.
Some data center spending will go to building and training new AI models. But some of it will go to building out new AI cloud services, like conversational AI, enterprise AI services, artificial intelligence agents, and video and image generation.
Global cloud revenue could reach $2 trillion by 2035 because of AI, according to Goldman Sachs, and as more of these AI cloud services come online, they'll likely be powered by Nvidia's processors.
3. The autonomous vehicle market could be huge
Nvidia develops its own technology for autonomous vehicles and has partnered with many automakers to bring its hardware and software components to the road. Most recently, Uber Technologies and Nvidia announced a new partnership that will utilize Nvida's generative AI tech to "supercharge the timeline for safe and scalable autonomous driving solutions for the industry," Uber CEO Dara Khosrowshahi said.
This is in addition to Nvidia's other partnerships, which include Toyota Motor, Volvo, BYD, and others. The market potential for autonomous vehicles is significant, with Move Strategy Consulting estimating it could be worth $2.3 trillion by 2030. And Nvidia is already benefiting. The company's automotive segment generated $449 million in the first quarter of fiscal year 2025 (which ended Oct. 31, 2024), an increase of 72% year over year.
The current autos segment growth gives Nvidia an estimated $5 billion annual run rate for its automotive segment sales this year. And Huang is very optimistic that there's plenty more opportunity. Speaking about autonomous vehicles at the recent CES conference, Huang said, "I predict that this will likely be the first multitrillion-dollar robotics industry."
Nvidia isn't cheap, but its AI potential remains high
Nvidia's stock has a forward price-to-earnings multiple of 32.5, compared to the S&P 500 's forward P/E of 24.5. That means you're not getting Nvidia at a discount if you buy its shares right now, but it's still relatively well priced amid a sea of AI stocks with much less potential.
Should you invest $1,000 in Nvidia right now?
Before you buy stock in Nvidia, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Nvidia wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $776,055!*
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*.
Learn more »
*Stock Advisor returns as of February 24, 2025

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Globe and Mail
8 hours ago
- Globe and Mail
Why AppFolio Stock Rocked the Market on Tuesday
One quite active stock mover on a forgettable Tuesday for the market was specialized business software developer AppFolio (NASDAQ: APPF). The company's shares saw a robust rise of almost 5% across the trading day, thanks to a pair of insider stock buys disclosed in regulatory filings. On that day, the S&P 500 (SNPINDEX: ^GSPC) also rose but by nowhere near as much, inching up to close the day 0.6% higher. A pair of very familiar stock buyers The two AppFolio folks snapping up shares of the company were members of its board of directors, Timothy Bliss and Casey Donald. Of the pair, Bliss was the more assertive, as he amassed 22,000 shares in a series of buys between last Thursday and the following Monday. The per-share price he paid for each of these blocks ranged from $215.28 to $218.73. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » As for Donald, his buying activity was more muted and concentrated. In a single purchase made last Friday, he snapped up 4,000 shares, paying an average of $217.73 apiece for the privilege. Shares of AppFolio, a software-as-a-service (SaaS) company that focuses on the real estate market, have seen something of an upswing lately. In no small part, this is a recovery from a sell-off following the company's first-quarter earnings release, published in late April. Although it posted solid growth on the top line, its net income fell, and it missed analyst estimates for both metrics. Lofty expectations We should bear in mind that investor expectations for the often-prosperous SaaS segment can be awfully high. Often, folks invested in industry titles demand not only strong, across-the-board growth; they insist on crushing beats too. To me, AppFolio is still doing very well in its niche, and remains robustly profitable despite that recent bottom-line dip. I think those insider buys were smart. Should you invest $1,000 in AppFolio right now? Before you buy stock in AppFolio, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and AppFolio wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $660,341!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $874,192!* Now, it's worth noting Stock Advisor 's total average return is999% — a market-crushing outperformance compared to173%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 9, 2025


Globe and Mail
8 hours ago
- Globe and Mail
Why Nvidia-Backed Navitas Semiconductor Soared Today
Shares of Navitas Semiconductor (NASDAQ: NVTS) surged higher on Tuesday, finishing the day up 11%. The gain came as the S&P 500 (SNPINDEX: ^GSPC) and the Nasdaq Composite (NASDAQINDEX: ^IXIC) were both up 0.6%. Positive news from ongoing trade talks between the U.S. and China is helping boost the company's stock as it continues its massive run-up following the revelation of its partnership with Nvidia. U.S. and China trade talks continue U.S. and Chinese officials are in London attempting to reach a more permanent resolution to the trade war that was put on pause last month. Commerce Secretary Howard Lutnick said on Tuesday that the discussions were "going well" and that the representatives were "spending lots of time together" attempting to reach a deal. A permanent reduction of the massive tariffs both countries imposed on each other in recent months would be great news for the entire economy, but semiconductor companies could benefit specifically, depending on the details. A critical partner Navitas announced last month that Nvidia had selected the company to help power its next-generation artificial intelligence (AI) data center systems, including the much-anticipated Rubin chips that will eventually succeed the current industry-leading Blackwell chips. Navitas, which specializes in gallium nitride (GaN) and silicon carbide (SiC) technologies, will help Nvidia solve key scaling issues with its power supply for the incredibly powerful AI-fueled chips. I think Navitas stock is worth owning; the seal of approval from Nvidia is huge. The company's balance sheet is solid, with minimal debt. Should you invest $1,000 in Navitas Semiconductor right now? Before you buy stock in Navitas Semiconductor, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Navitas Semiconductor wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $660,341!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $874,192!* Now, it's worth noting Stock Advisor 's total average return is999% — a market-crushing outperformance compared to173%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 9, 2025


Globe and Mail
11 hours ago
- Globe and Mail
Crinetics Pharmaceuticals Announces June 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, June 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on June 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of 74,000 shares of its common stock and granted an aggregate of 48,850 restricted stock unit ('RSU') awards to 20 new non-executive employees, in each case, under the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan (the '2021 Inducement Plan'). The stock options and RSUs were granted as inducements material to the employees entering into employment with Crinetics in accordance with Nasdaq Listing Rule 5635(c)(4). The 2021 Inducement Plan is used exclusively for granting equity awards to individuals who were not previously employees of Crinetics, or following a bona fide period of non-employment, as an inducement material to such individuals' entering into employment with Crinetics, pursuant to Nasdaq Listing Rule 5635(c)(4). The stock options have an exercise price of $33.08 per share, which is equal to the closing price of Crinetics' common stock on the Nasdaq Global Select Market on June 10, 2025. The shares subject to the stock options will vest over four years, with 25% of the shares vesting on the one-year anniversary of the applicable vesting commencement date and the balance of the shares vesting in a series of 36 successive equal monthly installments thereafter, subject to each employee's continued employment with Crinetics on such vesting dates. The RSUs will vest over four years in equal annual installments beginning on the one-year anniversary of the applicable vesting commencement date, also subject to each employee's continued employment with Crinetics on such vesting dates. The stock option and RSU awards are subject to the terms and conditions of the 2021 Inducement Plan and the terms and conditions of an applicable stock option award agreement or RSU award agreement covering the respective grant. About Crinetics Pharmaceuticals Crinetics Pharmaceuticals is a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for endocrine diseases and endocrine-related tumors. Crinetics' lead development candidate, paltusotine, is the first investigational once-daily, oral, selective somatostatin receptor type 2 (SST2) nonpeptide agonist that is in clinical development for acromegaly and carcinoid syndrome associated with neuroendocrine tumors. Atumelnant is currently in development for congenital adrenal hyperplasia and ACTH-dependent Cushing's syndrome. All of the company's drug candidates are orally delivered, small molecule, new chemical entities resulting from in-house drug discovery efforts, including additional discovery programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves' disease (including thyroid eye disease), diabetes, obesity and GPCR-targeted oncology indications. Investors: Gayathri Diwakar Head of Investor Relations gdiwakar@ (858) 345-6340